Literature DB >> 19221456

Endoscopic third ventriculostomy: 5 years' experience at the All India Institute of Medical Sciences.

A Garg1, A Suri, P S Chandra, R Kumar, B S Sharma, A K Mahapatra.   

Abstract

Endoscopic third ventriculostomy (ETV) is one of the efficacious surgical options available for obstructive hydrocephalus, and is preferable to a ventriculoperitoneal shunt in those eligible. We retrospectively studied 115 cases, who underwent ETV at our institute over the last 5 years. Thirty-eight patients were infants. Major indications for ETV were aqueductal stenosis (n = 60/115, 52.2%), Dandy-Walker malformation (15/115, 13%), associated arachnoid cyst (n = 13/115, 11.3%) and post-meningitic hydrocephalus (n = 12/115, 10.4%). Average duration of the follow-up was 10.6 months. Ninety-nine patients (86.1%) showed clinical improvement after surgery. Clinical improvement was seen in 27 out of 38 infants (71%) followed up. ETV is a highly effective tool in all age groups of patients for the management of hydrocephalus. Clinical features should be considered as indications of the success or failure of ventriculostomy in infants who have low-pressure hydrocephalus.

Entities:  

Mesh:

Year:  2009        PMID: 19221456     DOI: 10.1159/000202617

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  3 in total

1.  Single burr hole endoscopic biopsy with third ventriculostomy-measurements and computer-assisted planning.

Authors:  Hannah Knaus; Schultz Matthias; Arend Koch; Ulrich-W Thomale
Journal:  Childs Nerv Syst       Date:  2011-02-16       Impact factor: 1.475

2.  Influence of congenital central nervous system malformations on postoperative complications following placement of cerebrospinal fluid shunts in pediatric and adolescent patients.

Authors:  Marina Raguz; Nikolina Brcina; Davor Marinac; Miroslav Gjurasin
Journal:  Wien Klin Wochenschr       Date:  2013-10-29       Impact factor: 1.704

Review 3.  Limitations of Neuroendoscopic Treatment for Pediatric Hydrocephalus and Considerations from Future Perspectives.

Authors:  Kenichi Nishiyama; Junichi Yoshimura; Yukihiko Fujii
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-07-28       Impact factor: 1.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.